Ajanta Pharma Ltd (AJANTPHARM) — Announcement | 25 September 2026
Ajanta Pharma announced that its insider trading window will close on 1 October 2026 and remain shut for 48 hours after the Q2 and H1 results ending 30 September 2026, restricting insiders from trading during this period.
About Ajanta Pharma Ltd (AJANTPHARM)
Healthcare · Pharmaceuticals · Listed on BSE
📡 Get AI alerts when AJANTPHARM files next
Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions
Track AJANTPHARM — Free💡 Ask AI about this filing
📊 More AJANTPHARM filings
- 🟡 Sustainability Report — 30 September 2026Ajanta Pharma submitted its FY 2025-26 Sustainability Report, detailing ESG performance across envir...
- 🔴 Insider Trading — 28 September 2026Promoter Aayush Agrawal released pledges on 98,185 shares of Ajanta Pharma Ltd on 28 September 2026 ...
- Announcement — 31 August 2026Ajanta Pharma announced its schedule for upcoming investor meetings with Jefferies India Forum on Se...
- 🔴 Insider Trading — 27 August 2026Ajanta Pharma Ltd disclosed that promoter group entities including Yogesh Agrawal Trust, Rajesh Agra...
- Announcement — 5 August 2026Ajanta Pharma announced its schedule for analyst and institutional investor meetings in August 2026,...
🔥 Also filed on 25 September 2026
Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.
Editorial & Data Transparency Notice
This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.
📡 Get AI alerts when AJANTPHARM files new disclosures
Track AJANTPHARM filings, board meetings, and corporate actions. Free email alerts at 5 PM.
Track AJANTPHARM — FreeFree account · 2 AI queries/day